<html><head><link rel="stylesheet" href="https://unpkg.com/mvp.css"></head><title>Complaint to NPPA</title><body><h1>Complaint to NPPA</h1><p style="text-align:justify">Companies introducing 22 drugs without prior approval of the National Pharmaceutical Pricing Authority (NPPA) have been issued notices.  The list of companies and the drugs are as in the list below:</p>
<p style="text-align:justify">S. No.</p>
<p style="text-align:justify">Name of the Company</p>
<p style="text-align:justify">Name of the Drug</p>
<p style="text-align:justify">1</p>
<p style="text-align:justify">Alembic Pharmaceuticals Ltd</p>
<p style="text-align:justify">Resync 75/50 mg</p>
<p style="text-align:justify">2</p>
<p style="text-align:justify">Alembic Pharmaceuticals Ltd</p>
<p style="text-align:justify">Trivogo  tablet</p>
<p style="text-align:justify">3</p>
<p style="text-align:justify">Biocon limited</p>
<p style="text-align:justify">Blisto Trio 0.2/500/2 mg</p>
<p style="text-align:justify">4</p>
<p style="text-align:justify">Biocon limited</p>
<p style="text-align:justify">Blisto Trio 0.2/500/1 mg</p>
<p style="text-align:justify">5</p>
<p style="text-align:justify">BoehringerIngelheim India Pvt. Ltd and Kemwell Biopharma Pvt. Ltd</p>
<p style="text-align:justify">Buscogast plus Tablets</p>
<p style="text-align:justify">6</p>
<p style="text-align:justify">Cipla Limited</p>
<p style="text-align:justify">Hepcvel Tablets</p>
<p style="text-align:justify">7</p>
<p style="text-align:justify">Dr. Reddy,s Laboratories Ltd</p>
<p style="text-align:justify">Resof total 400/100 mg</p>
<p style="text-align:justify">8</p>
<p style="text-align:justify">Eris Life Sciences Pvt Ltd</p>
<p style="text-align:justify">Cyblex MV 80.3</p>
<p style="text-align:justify">9</p>
<p style="text-align:justify">Eris Life Sciences Pvt Ltd</p>
<p style="text-align:justify">Cyblex M 30</p>
<p style="text-align:justify">10</p>
<p style="text-align:justify">Eris Life Sciences Pvt Ltd</p>
<p style="text-align:justify">Cyblex M 60</p>
<p style="text-align:justify">11</p>
<p style="text-align:justify">Eris Life Sciences Pvt Ltd</p>
<p style="text-align:justify">Cyblex MV 80.2</p>
<p style="text-align:justify">12</p>
<p style="text-align:justify">Eris Life Sciences Pvt Ltd</p>
<p style="text-align:justify">Cyblex M 80</p>
<p style="text-align:justify">13</p>
<p style="text-align:justify">Eris Life Sciences Pvt Ltd</p>
<p style="text-align:justify">Cyblex M 40</p>
<p style="text-align:justify">14</p>
<p style="text-align:justify">Hetero Healthcare Limited</p>
<p style="text-align:justify">Velasof Tablets</p>
<p style="text-align:justify">15</p>
<p style="text-align:justify">Hetero Healthcare Limited / Cadila Healthcare Limited</p>
<p style="text-align:justify">Sovip V Tablets</p>
<p style="text-align:justify">16</p>
<p style="text-align:justify">Ipca Laboratories Limited</p>
<p style="text-align:justify">Pacimol Active</p>
<p style="text-align:justify">17</p>
<p style="text-align:justify">lupin limited</p>
<p style="text-align:justify">Gluconorm VG pluse-1</p>
<p style="text-align:justify">18</p>
<p style="text-align:justify">lupin limited</p>
<p style="text-align:justify">Gluconorm VG pluse-2</p>
<p style="text-align:justify">19</p>
<p style="text-align:justify">Sanofi India Limited</p>
<p style="text-align:justify">Amaryl MV 0.2 mg /500/1 mg</p>
<p style="text-align:justify">20</p>
<p style="text-align:justify">Sanofi India Limited</p>
<p style="text-align:justify">Amaryl MV 0.2 mg /500/1 mg pack of 15 tabs</p>
<p style="text-align:justify">21</p>
<p style="text-align:justify">Unichem Laboratories pvt.ltd</p>
<p style="text-align:justify">Tritelsar-80+5 similer formulation</p>
<p style="text-align:justify">22</p>
<p style="text-align:justify">Wockhardt Liited and  Medibios Laboratories Limited </p>
<p style="text-align:justify">Alphadopa 500mg  tab</p>
<p style="text-align:justify"> </p>
<p style="text-align:justify">The NPPA regularly takes action against such companies as per provisions of the Drugs (Prices Control) Order, 2013 (DPCO) which has been issued under the Essential Commodities Act, 1955.  The NPPA has so far issued demand notices for an amount of Rs. 101 crore against defaulting companies. Out of this, an amount of Rs. 5.56 crore has been recovered and demand notices amounting to Rs. 89.31 crore are under litigation.  </p>
<p style="text-align:justify">Cases of new drugs are identified from the market-based data being referred to by the NPPA. In addition, new drug cases are also identified through complaint or information received from other sources. </p>
<p style="text-align:justify">This information was given in a written reply by the Union Minister for the Chemicals &#038; Fertilizers, Shri D .V. Sadananda  Gowda in the Lok  Sabha today.</p>
<p style="text-align:justify">
</body></html>